|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07F 9/24 | |
| A61K 31/675 | |||
| C07F 9/655 |
| (11) | Number of the document | 3390413 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16876437.1 |
| Date of filing the European patent application | 2016-12-12 | |
| (97) | Date of publication of the European application | 2018-10-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/066075 |
| Date | 2016-12-12 |
| (87) | Number | WO 2017/106069 |
| Date | 2017-06-22 |
| (30) | Number | Date | Country code |
| 201562267505 P | 2015-12-15 | US |
| (72) |
FU, Wenlang, US
GUO, Zhiqiang, US
QI, Ning, US
RAHEEM, Izzat, T., US
VACHAL, Petr, US
WANG, Ming, US
SCHREIER, John, D., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | ANTIVIRAL OXIME PHOSPHORAMIDE COMPOUNDS |
| ANTIVIRAL OXIME PHOSPHORAMIDE COMPOUNDS |